Výsledky vyhledávání - "Al‐Khatib, Hani"

Akademický článek

Antibiotic Prescribing in Acute Wound Management.

Autor: Al-khatib, Hani Dourado¹, Corn, Emma¹, Ozidu, Victoria¹

Publikováno v: BJPsych Open. 2024 Supplement 1, Vol. 10, pS227-S228. 2p.

Zobrazit plný text záznamu

Akademický článek

Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications.

Autor: Ashrani, Aneel A., Aysola, Agnes, Al-Khatib, Hani, Nichols, William L., Key, Nigel S.

Publikováno v: British Journal of Haematology; May2003, Vol. 121 Issue 4, p639-642, 4p

Zobrazit plný text záznamu

Periodical

Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinomaAdditional participating institutions include the following: St. Cloud, Minnesota (Harold E. Windschitl, M.D.); Saskatchewan Cancer Centre, Saskatoon, and Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (Muhammad Salim, M.D.); Ann Arbor Regional Community Clinical Oncology Program, Ann Arbor, Michigan (Philip J. Stella, M.D.); Medcenter One Health Systems, Bismarck, North Dakota (Ferdinand Addo, M.D.); Cedar Rapids Oncology Project Community Clinical Oncology Program, Cedar Rapids, Iowa (Martin Wiesenfeld, M.D.); Altru Health Systems, Grand Forks, North Dakota (Daniel J. Walsh, M.D.); Siouxland Hematology‐Oncology Associates, Sioux City, Iowa (John C. Michalak, M.D.); and Missiouri Valley Cancer Consortium, Omaha, Nebraska (James A. Mailliard, M.D.).: A North Central Cancer Treatment Group Phase II Trial

Autor: Alberts, Steven R., Al‐Khatib, Hani, Mahoney, Michelle R., Burgart, Lawerence, Cera, Peter J., Flynn, Patrick J., Finch, Tom R., Levitt, Ralph, Windschitl, Harold E., Knost, James A., Tschetter, Loren K.

Publikováno v: Cancer; January 2005, Vol. 103 Issue: 1 p111-118, 8p

Zobrazit plný text záznamu

Akademický článek

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.

Autor: Alberts SR; Division of Medical Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. alberts.steven@mayo.edu, Al-Khatib H, Mahoney MR, Burgart L, Cera PJ, Flynn PJ, Finch TR, Levitt R, Windschitl HE, Knost JA, Tschetter LK

Publikováno v: Cancer [Cancer] 2005 Jan 01; Vol. 103 (1), pp. 111-8.

Zobrazit plný text záznamu